[{"NetIncomeLoss_1_Q1_USD":-10154000.0,"HeldToMaturitySecurities_0_Q1_USD":60359000.0,"MarketableSecuritiesCurrent_0_Q1_USD":47248000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":9333000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":36210000.0,"GainLossOnSaleOfPropertyPlantEquipment_1_Q1_USD":0.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-320000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-2674000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":129403000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":1175350.0,"CurrentFederalTaxExpenseBenefit_1_Q1_USD":-226000.0,"AssetsCurrent_0_Q1_USD":386124000.0,"DueToRelatedPartiesNoncurrent_0_Q1_USD":71308000.0,"CurrentStateAndLocalTaxExpenseBenefit_1_Q1_USD":-94000.0,"DueToRelatedPartiesCurrent_0_Q1_USD":18684000.0,"IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_1_Q1_USD":17000.0,"IncomeTaxesPaidNet_1_Q1_USD":66000.0,"CommonStockSharesIssued_0_Q1_shares":38271641.0,"PaymentsForRepurchaseOfEquity_1_Q1_USD":285000.0,"Assets_0_Q1_USD":397949000.0,"DebtAndEquitySecuritiesUnrealizedGainLoss_1_Q1_USD":-35000.0,"ShareBasedCompensation_1_Q1_USD":3400000.0,"Liabilities_0_Q1_USD":161412000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":3501000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":643183000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":327137000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":20806000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-3070000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":11684000.0,"AccountsReceivableNetCurrent_0_Q1_USD":294000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q1_pure":0.884,"IncomeTaxExpenseBenefit_1_Q1_USD":49000.0,"CommonStockValue_0_Q1_USD":3940000.0,"Revenues_1_Q1_USD":8350000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":324000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q1_USD":12203000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":150457000.0,"DeferredStateAndLocalIncomeTaxExpenseBenefit_1_Q1_USD":108000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":18128000.0,"DeferredRevenueNoncurrent_0_Q1_USD":34752000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":374400000.0,"OtherAssetsCurrent_0_Q1_USD":1366000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q1_USD":22356000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":756000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":74000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q1_pure":0.006,"OtherAssetsNoncurrent_0_Q1_USD":1872000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":2397000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":37396000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":129568000.0,"CommonStockParOrStatedValuePerShare_0_Q1_EUR":0.09,"ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_1_Q1_USD":200000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":164056000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":340000.0,"CommonStockSharesOutstanding_0_Q1_shares":38271641.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":20645000.0,"DeferredFederalIncomeTaxExpenseBenefit_1_Q1_USD":261000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-10105000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":3400000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-9391000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":19343000.0,"LiabilitiesCurrent_0_Q1_USD":52955000.0,"DeferredRevenueCurrent_0_Q1_USD":7070000.0,"AccountsPayableCurrent_0_Q1_USD":3715000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":327338000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":9814000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":4697000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":437000.0,"OperatingLeasePayments_1_Q1_USD":435000.0,"HeldToMaturitySecuritiesFairValue_0_Q1_USD":60359000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":25000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":3766000.0,"LeaseCost_1_Q1_USD":509000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":41000.0,"CurrentIncomeTaxExpenseBenefit_1_Q1_USD":-320000.0,"VariableLeaseCost_1_Q1_USD":91000.0,"InterestReceivableCurrent_0_Q1_USD":29000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":17.8,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":1574000.0,"CommonStockSharesAuthorized_0_Q1_shares":45000000.0,"OperatingIncomeLoss_1_Q1_USD":-21789000.0,"OtherNonoperatingExpense_1_Q1_USD":437000.0,"StockRepurchasedDuringPeriodValue_1_Q1_USD":285000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":369000.0,"OperatingLeaseCost_1_Q1_USD":418000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":397949000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":2584000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":3400000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1130000.0,"OperatingExpenses_1_Q1_USD":30139000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":1130000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.28,"ProfitLoss_1_Q1_USD":-10154000.0,"StockholdersEquity_0_Q1_USD":236537000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":157000.0,"IntangibleAssetsNetIncludingGoodwill_0_Q1_USD":2645000.0,"AccountsReceivableRelatedPartiesCurrent_0_Q1_USD":1631000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-410266000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q1_USD":-19545000.0,"Ticker":"MRUS","CIK":"1651311","name":"MERUS N.V.","OfficialName":"Merus N.V. Common Shares","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1055622823.0","Country":"Netherlands","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210506"}]